Clearpoint Neuro Short Long Term Debt Total Over Time

CLPT Stock  USD 14.53  0.32  2.25%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Clearpoint Neuro Performance and Clearpoint Neuro Correlation.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.
  
Short and Long Term Debt Total is likely to drop to about 3.4 M in 2025.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearpoint Neuro. If investors know Clearpoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearpoint Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
1.158
Quarterly Revenue Growth
0.41
Return On Assets
(0.28)
Return On Equity
(0.68)
The market value of Clearpoint Neuro is measured differently than its book value, which is the value of Clearpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Clearpoint Neuro's value that differs from its market value or its book value, called intrinsic value, which is Clearpoint Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearpoint Neuro's market value can be influenced by many factors that don't directly affect Clearpoint Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearpoint Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearpoint Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearpoint Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Short Long Term Debt Total Analysis

Compare Clearpoint Neuro and related stocks such as Telesis Bio, Avita Medical, and Sight Sciences Short Long Term Debt Total Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
2010201120122013201420152016201720182019202020212022202320242025
RCEL7760.00.00.00.00.00.0134.2 K37.9 K37.9 K2.8 M1.9 M449.5 K449.5 K516.9 K434.7 K
SGHT13.9 M13.9 M13.9 M13.9 M13.9 M13.9 M13.9 M13.9 M13.9 M13.9 M32.5 M33.2 M34.3 M35.4 M40.7 M32.9 M
TMCI19.2 M19.2 M19.2 M19.2 M19.2 M19.2 M19.2 M19.2 M19.2 M19.2 M31 M29.4 M68.6 M70.3 M80.8 M48.1 M
NPCE62.8 M62.8 M62.8 M62.8 M62.8 M62.8 M62.8 M62.8 M62.8 M62.8 M52.9 M49.8 M69.8 M72.4 M83.3 M67.7 M
INGN9.6 M9.6 M8.9 M10.6 M614 K315 K6.7 M6.7 M6.7 M6.7 M10 M26.7 M23.3 M21.9 M25.2 M13.1 M
SRDX436 K436 K436 K436 K436 K436 K436 K436 K436 K436 K10 M13.8 M29.4 M33.2 M38.2 M19.1 M
LUNG33.6 M33.6 M33.6 M33.6 M33.6 M33.6 M33.6 M33.6 M33.6 M21.8 M27.2 M26.5 M24.4 M41.4 M56.5 M36.4 M
APYX811.2 K4.2 M3.5 MM16 M3.6 M3.1 M2.8 M140 K1.1 M676 K305 K796 K38.5 M44.3 M46.5 M
LIVN300 KK176.8 M176.8 M176.8 M176.8 M122.9 M146 M168.3 M383.7 M697.8 M275.4 M571 M640.4 M627 M658.3 M
ELMD3.1 M3.4 M1.4 M1.3 M1.3 M1.2 M1.1 M1.1 M45.1 K81.2 K87 K41 K161 K87 K78.3 K74.4 K
KIDS13.2 M13.2 M13.2 M13.2 M13.2 M13.1 M17.5 M25.5 M21.3 M26.3 M1.5 MM907 K10.1 M9.1 M10.4 M
NARI9.8 M9.8 M9.8 M9.8 M9.8 M9.8 M9.8 M9.8 M9.8 M19.5 M29.2 M29.2 M32.3 M32 M36.9 M27 M
OM28.9 M28.9 M28.9 M28.9 M28.9 M28.9 M28.9 M28.9 M28.9 M29.1 M38.6 M37.8 M103.2 M136.2 M156.6 M164.4 M
INSP15.7 M15.7 M15.7 M15.7 M15.7 M15.7 M15.7 M16.5 M24.9 M25.4 M30.6 M33.8 M8.9 M24.8 M30 M25.7 M
CTSO60 K570.6 K926.2 K1.6 M4.9 M4.9 M4.9 M10 M9.9 M16.1 MM13.8 M18.3 M18.3 M21.1 M22.1 M
TELA6.2 M6.2 M6.2 M6.2 M6.2 M6.2 M6.2 M6.2 M29.7 M30.2 M30.8 M31.5 M40.3 M41.1 M47.2 M33 M
JavaScript chart by amCharts 3.21.15Macroaxis Charts2012201420162018202020222024 100M200M300M400M500M600M700M
JavaScript chart by amCharts 3.21.15Sight Sciencestotal: 348.4MTreace Medical Conceptstotal: 520.4MNeuropacetotal: 1BInogen Inctotal: 186.8MSurModicstotal: 148.2MPulmonx Corptotal: 536.6MApyx Medicaltotal: 175.4MLivaNova PLCtotal: 5BElectromedtotal: 14.6MOrthopediatrics Corptotal: 202.8MInari Medicaltotal: 294.6MOutset Medicaltotal: 925.7MInspire Medical Systemstotal: 330.5MCytosorbents Crptotal: 148.6MTela Biototal: 333.5M

Clearpoint Neuro and related stocks such as Telesis Bio, Avita Medical, and Sight Sciences Short Long Term Debt Total description

My Equities

My Current Equities and Potential Positions

Clearpoint Neuro
CLPT
Specialization
Health Care, Health Care Equipment & Services
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
USD 13.82

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.